Serum levels of Vanin-1 have been associated with hepatic lipoplasia and have been considered as a non-invasive inflammatory marker for non-alcoholic steatohepatitis (12). This evidence concerns the gene VNN1 and metabolic dysfunction-associated steatohepatitis.